Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.

12 Issues per year

IMPACT FACTOR 2016: 3.432

CiteScore 2016: 2.21

SCImago Journal Rank (SJR) 2016: 1.000
Source Normalized Impact per Paper (SNIP) 2016: 1.112

See all formats and pricing
More options …
Volume 45, Issue 5 (May 2007)


Mesothelin family proteins and diagnosis of mesothelioma: analytical evaluation of an automated immunoassay and preliminary clinical results

Francesca Di Serio / Antonietta Fontana / Michele Loizzi / Giuseppe Capotorto / Piera Maggiolini / Ernesto Mera / Lucia Bisceglia
  • 7Section of Environmental and Occupational Epidemiology and Ergonomics, University Hospital of Bari, Bari, Italy
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Raffaele Molinini
Published Online: 2007-05-07 | DOI: https://doi.org/10.1515/CCLM.2007.112


Background: Studies have suggested that soluble mesothelin-related protein (SMRP) can be used as a serum marker of malignant mesothelioma.

Methods: We assessed the analytical performance of the Mesomark (Fujirebio Diagnostic) two-step ELISA on an automated analyser and performed a preliminary clinical evaluation. The precision of the assay and the in vitro effect of interfering substances on SMRP concentrations were investigated. The serum marker was analysed in 109 healthy subjects never exposed to asbestos, 26 healthy subjects exposed to asbestos, 33 patients with asbestosis, 33 with asbestos-related pleural plaques, 10 with non-malignant pleural diseases, 30 with lung cancer and 24 with histological diagnosis of pleural mesothelioma.

Results: Using the International Mesothelioma Interest Group classification, there were nine stage IV, two stage III, four stage II and nine stage I patients. SMRP concentrations of 4.75, 11.0 and 14 nmol/mL showed a total imprecision of 3.5%, 3.1% and 3.8%. The detection limit was 0.035 nmol/mL; the mean SMRP concentration of 0.63 nmol/mL was associated with a coefficient of variation of 10%. There was no effect (p>0.05) of interfering substances. Serum samples from patients with established pleural mesothelioma had significantly higher (p<0.05) concentrations of SMRP than control healthy and patient groups.

Conclusions: SMRP measured on automated systems could be useful for the diagnosis of mesothelioma in routine clinical practice.

Clin Chem Lab Med 2007;45:634–8.

Keywords: mesothelioma; soluble mesothelin-related peptides

About the article

Corresponding author: Francesca Di Serio, Department of Clinical Pathology I, University Hospital of Bari, Piazza Giulio Cesare N. 11, 70124 Bari, Italy Phone: +39-080-5592629, Fax: +39-080-5592124,

Received: 2006-11-23

Accepted: 2007-01-29

Published Online: 2007-05-07

Published in Print: 2007-05-01

Citation Information: Clinical Chemical Laboratory Medicine, ISSN (Online) 14346621, ISSN (Print) 14374331, DOI: https://doi.org/10.1515/CCLM.2007.112.

Export Citation

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

Kevin Hollevoet, Johannes B. Reitsma, Jenette Creaney, Bogdan D. Grigoriu, Bruce W. Robinson, Arnaud Scherpereel, Alfonso Cristaudo, Harvey I. Pass, Kristiaan Nackaerts, José A. Rodríguez Portal, Joachim Schneider, Thomas Muley, Francesca Di Serio, Paul Baas, Marco Tomasetti, Alex J. Rai, and Jan P. van Meerbeeck
Journal of Clinical Oncology, 2012, Volume 30, Number 13, Page 1541
Joost P.J.J. Hegmans, Joris D. Veltman, Eric T. Fung, Thorsten Verch, Curtis Glover, Fujun Zhang, W. Jeffrey Allard, Davy T'Jampens, Henk C. Hoogsteden, Bart N. Lambrecht, and Joachim Aerts
Technology in Cancer Research & Treatment, 2009, Volume 8, Number 5, Page 323
Daniel G. Weber, Swaantje Casjens, Georg Johnen, Oleksandr Bryk, Irina Raiko, Beate Pesch, Jens Kollmeier, Torsten T. Bauer, Thomas Brüning, and Deborah A. Altomare
PLoS ONE, 2014, Volume 9, Number 12, Page e114483
Heather H. Nelson, Lindsay M. Almquist, Jessica L. LaRocca, Silvia L. Plaza, Geralyn M. Lambert-Messerlian, David J. Sugarbaker, Raphael Bueno, John J. Godleski, Carmen J. Marsit, Brock C. Christensen, and Karl T. Kelsey
Epigenetics, 2011, Volume 6, Number 8, Page 1029
Petr Jakubec, Daniela Pelclova, Petra Smolkova, Vitezslav Kolek, and Marie Nakladalova
Biomedical Papers, 2014
Kevin Hollevoet, Kristiaan Nackaerts, Joël Thimpont, Paul Germonpré, Lionel Bosquée, Paul De Vuyst, Catherine Legrand, Eliane Kellen, Yoshiro Kishi, Joris R. Delanghe, and Jan P. van Meerbeeck
American Journal of Respiratory and Critical Care Medicine, 2010, Volume 181, Number 6, Page 620
Eun-Kee Park, Alessandra Sandrini, Deborah H. Yates, Jenette Creaney, Bruce W. Robinson, Paul S. Thomas, and Anthony R. Johnson
American Journal of Respiratory and Critical Care Medicine, 2008, Volume 178, Number 8, Page 832
Ling Luo, Huan-Zhong Shi, Qiu-Li Liang, Jing Jiang, Shou-Ming Qin, and Jing-Min Deng
Respiratory Medicine, 2010, Volume 104, Number 1, Page 149
Steven Chuan-Hao Kao, Glen Reid, Nico van Zandwijk, Douglas W. Henderson, and Sonja Klebe
Pathology, 2011, Volume 43, Number 3, Page 201
Eun-Kee Park, Paul S. Thomas, Jenette Creaney, Anthony R. Johnson, Bruce W. Robinson, and Deborah H. Yates
Clinical Chemistry and Laboratory Medicine, 2010, Volume 48, Number 6
Eun-Kee Park, Deborah H. Yates, Paul S. Thomas, and Anthony R. Johnson
Clinical Chemistry and Laboratory Medicine, 2008, Volume 46, Number 4
Giorgio Vittorio Scagliotti and Giovanni Selvaggi
Oncology Reviews, 2007, Volume 1, Number 2, Page 91

Comments (0)

Please log in or register to comment.
Log in